Biomarker and more: can translocator protein 18 kDa predict recovery from brain injury and myocarditis?
Could monitoring methylation markers aid the management of schizophrenia?
Take a deep breath: novel markers for larynx cancer observed
Prostate cancer diagnostic offers more specificity than traditional methods
VolitionRx and University Hospital Bonn to commence CE mark performance evaluation
US FDA approval for a human papillomavirus test for primary cervical cancer screening
Highlights from the field of biomarkers in melanoma
Biomarkers and aging
Development of NuQ® nucleosome blood tests for the detection of colon cancer
Dynamic sequencing of circulating tumor DNA: novel noninvasive cancer biomarker
Pilot study of A-FABP levels as a predictive factor of SPECT results in asymptomatic relatives of patients with cardiovascular disease
Sialylation of Thomsen–Friedenreich antigen is a noninvasive blood-based biomarker for GNE myopathy
Circulating microparticles reflect treatment effects and clinical status in multiple sclerosis
Serum HER2 extracellular domain as a potential alternative for tissue HER2 status in metastatic gastric cancer patients
KLK11 mRNA expression predicts poor disease-free and overall survival in colorectal adenocarcinoma patients
IGFBP1 in epithelial circulating tumor cells as a potential response marker to selective internal radiation therapy in hepatocellular carcinoma
Novel single-chain antibody GD3A10 defines a chondroitin sulfate biomarker for ovarian cancer
Biomarkers of cartilage and surrounding joint tissue
miRNA panels as biomarkers for bladder cancer
Implementation of PSA-based active surveillance in prostate cancer
Detection of colorectal cancer by DNA methylation biomarker SEPT9: past, present and future